Prescribing medications for geriatric patients in the managed care setting

American Journal of Managed Care

Volumn 6, Issue 5, 2000, Pages 610-618

  Golden, Adam G ^a,b,e   Silverman, Michael A ^a,b,c,d   Preston, Richard A ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Education   (United States)

^c Stein Gerontological Institute   (United States)

^d Eldercare   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMPHETAMINE; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETHANECHOL; CHLORPROTHIXENE; CLOZAPINE; CORTICOSTEROID; DECONGESTIVE AGENT; DESIPRAMINE; DIGOXIN; DISOPYRAMIDE; GASTROINTESTINAL AGENT; HYPNOTIC AGENT; INDOMETACIN; METHYLPHENIDATE; MUSCLE RELAXANT AGENT; NARCOTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OXYBUTYNIN; PARACETAMOL; POTASSIUM; SEDATIVE AGENT; SEROTONIN UPTAKE INHIBITOR; THEOPHYLLINE; THIORIDAZINE; TICLOPIDINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

AGED; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONSTIPATION; DELIRIUM; DIABETES MELLITUS; DUODENUM BLEEDING; HEART FAILURE; HUMAN; HYPERTENSION; INCONTINENCE; INSOMNIA; MANAGED CARE; ORTHOSTATIC HYPOTENSION; PERIPHERAL VASCULAR DISEASE; PRESCRIPTION; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; REVIEW; SEIZURE; ULCER; URINE INCONTINENCE;

ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; CLINICAL PHARMACY INFORMATION SYSTEMS; EDUCATION, CONTINUING; HEALTH SERVICES FOR THE AGED; HUMANS; MANAGED CARE PROGRAMS; PATIENT COMPLIANCE; PHARMACISTS; PRACTICE GUIDELINES; PRESCRIPTIONS, DRUG;

EID: 0034103978     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. Schwartz JB. Geriatric clinical pharmacology. In: Kelly W, ed. Textbook of Internal Medicine. 3rd ed. New York, NY: Lippincott-Raven;1997:2547-2554.
2. Stuck AE, Beers MH, Steiner A, et al. Inappropriate medication use in community-residing older persons. Arch Intern Med 1994;154:2195-2200.
3. Hurwitz A, Brady DA, Schaal SE, et al. Gastric acidity in older adults. JAMA 1997;278:659-662.
4. Golden AG, Silverman MA, Preston RA. University of Miami Division of Clinical Pharmacology therapeutic rounds: Issues in prescribing for geriatric patients and emerging practice guidelines. Am J Ther 1999;6:341-348.
5. Colley CA, Lucas LM. Polypharmacy: The cure becomes the disease. J Gen Intern Med 1993;8:278-283
6. Stewart RB, Moore MT, May FE, et al. Changing patterns of therapeutic agents in the elderly: A 10-year overview. Age Ageing 1991;20:182-188
7. Hurwitz N. Predisposing factors in adverse drug reactions. BMJ 1969;1(643):536-539.
8. Lindley CM, Tully MP, Paramsoth V, Tallis RC. Inappropriate medication is a major cause of adverse drug reactions in elderly patients. Age Ageing 1992;21:294-300.
9. Gibian T. Rational drug therapy in the elderly, or how not to poison your elderly patients. Aust Fam Physician 1992;21:1755-1759.
10. Kane RL, Ouslander JG, Abrass IB. Drug therapy. In: Essentials of Clinical Geriatrics. 3rd ed. New York, NY: McGraw-Hill Co;1994:350-384.
11. Vogenberg FR. Trends in managed care pharmacy benefits. Hosp Pharm 1999;34:1263-1267.
12. Motheral BR, Henderson R. The effect of a copay increase on pharmaceutical utilization, expenditures, and treatment continuation. Am J Manag Care 1999;5:1383-1394.
13. Halas C. Optimizing drug use in elderly patients. Am Druggist February, 1999:56-62.
14. Rochon PA, Gurwitz JH. Prescribing for seniors, neither too much nor too little. JAMA 1999;282:113-115.
15. Krumholz HM, Radford MJ, Wang Y, et al. Early β-blocker therapy for acute myocardial infarction in elderly patients. Ann Intern Med 1999;131:648-654.
16. Giugliano RP, Camargo CA, Lloyd-Jones DM, et al. Elderly patients receive less aggressive medical and invasive management of unstable angina. Arch Intern Med 1997;158:1113-1120.
17. Krumholz HM, Radford MJ, Wang Y, et al. National use and effectiveness of β-blockers for the treatment of elderly patients after acute myocardial infarction. JAMA 1998;280:623-629.
18. Krumholz HM, Radford MJ, Ellerbeck EF, et al. Aspirin for secondary prevention after acute myocardial infarction in the elderly: Prescribed use and outcomes. Ann Intern Med 1996;124:292-298.
19. Berlowitz DR, Ash AS, Hickey EC, et al. Inadequate management of blood pressure in a hypertensive population. N Engl J Med 1998;339:1957-1963.
20. Havranek EP, Abrams F, Stevens E, Parker K. Determinants of mortality in elderly patients with heart failure. Arch Intern Med 1998;158:2024-2028.
21. Gattis WA, Larsen RL, Hasselblad V, et al. Is optimal angiotensin-converting enzyme inhibitor dosing neglected in elderly patients with heart failure? Am Heart J 1998;136:43-48.
22. Barron HV, Michaels AD, Maynard C, Every NR. Use of angiotensin-converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States: Data from the National Registry of Myocardial Infarction 2. J Am Coll Cardiol 1998;32:360-367.
23. Handa VL, Landerman R, Hanlon JT, et al. Do older women use estrogen replacement? Data from the Duke Established Populations for Epidemiologic Studies of the Elderly (EPESE). J Am Geriatr Soc 1996;44:1-6.
24. Williams JW, Mulrow CD, Kroenke K, et al. Case-finding for depression in primary care: A randomized trial. Am J Med 1999;106:36-43.
25. Redelmeir DA, Tan SH, Booth GL. The treatment of unrelated disorders in patients with chronic medical diseases. N Engl J Med 1998;338:1516-1520.
26. Bender K, McKenzie MW, Stewart RB. Defining the adverse drug reaction sequence. J Am Pharm Assoc 1976; 76:244-247.
27. Montamat SC, Cusack BJ, Vestal RE. Management of drug therapy in the elderly. N Engl J Med 1989;321:303-310.
28. Cadieux RJ. Drug interactions in the elderly: How multiple drug use increases risk exponentially. Postgrad Med 1989;86:179-186.
29. Nolan L, O'Malley K. Prescribing for the elderly, I: Sensitivity of the elderly to adverse drug reactions. J Am Geriatr Soc 1988;36:142-149.
30. Steel K, Gertman PM, Crescenzi Anderson J. Iatrogenic illness on a general medical service at a university hospital. N Engl J Med 1981;304:638-642.
31. Beers MH, Fingold SF, Ouslander JG, et al. Characteristics and quality of prescribing by doctors practicing in nursing homes. J Am Geriatr Soc 1993;41:802-807.
32. Brewer T, Colditz GA. Postmarketing surveillance and adverse drug reactions. JAMA 1999;281:824-829.
33. Williams B, Betley C. Inappropriate use of nonpsychotropic medications in nursing homes. J Am Geriatr Soc 1995;43:513-519.
34. Willcox SM, Himmelstein DU, Woolhander S. Inappropriate drug prescribing for the community-dwelling elderly. JAMA 1994;272:292-296.
35. Golden A, Preston RA, Llorente MA, et al. Inappropriate prescribing in home-bound older adults. J Am Geriatr Soc 1999;47:948-953.
36. Aparasu RR, Fliginger SE. Inappropriate medication prescribing for the elderly by office-based physicians. Ann Pharmacother 1997;31:823-829.
37. Schmader KE, Hanlon JT, Landsman PB, et al. Inappropriate prescribing and health outcomes in elderly veteran outpatients. Ann Pharmacother 1997;31:529-533.
38. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. Arch Intern Med 1997;157:1531-1536.
39. Tinetti ME, Speechley M. Prevention of falls among the elderly. N Engl J Med 1989;320:1055-1059.
40. Ray WA, Griffin MR, Downey W. Benzodiazepines of long and short elimination half-life and the risk of hip fracture. JAMA 1989;262:3303-3307.
41. Ried LD, Johnson RE, Gettman DA. Benzodiazepine exposure and functional status in older people. J Am Geriatr Soc 1998;46:71-76.
42. Nowell PR, Mazumdar S, Buysse DJ, et al. Benzodiazepines and zolpidem for chronic insomnia. JAMA 1997;278:2170-2177.
43. 1 antihistamines in elderly patients: Considerations in a polypharmaceutical patient population. Clin Geriatr 1997;5:75-88.
44. Diener HC, Cunha L, Forbes J, et al. European Stroke Prevention Study 2: Dypyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996;143:1-13.
45. 2-receptor antagonists for heartburn. Med Lett Drugs Ther 1995;37:95-96.
46. Shorr RI, Ray WA, Daugherty JR, Griffin MR. Individual sulfonyureas and serious hypoglycemia in older people. J Am Geriatr Soc 1996;44:751-755.
47. Morley JE. Anorexia of aging: Physiologic and pathologic. Am J Clin Nutr 1997;66:760-773.
48. Bjorkman DJ. Nonsteroidal anti-inflammatory drug-induced gastrointestinal injury. Am J Med 1996;101(suppl):25S-31S.
49. Garcia Rodriguez LA, Cattaruzzi C, Troncon MG, Agostinis L. Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other anti-hypertensive drugs. Arch Intern Med 1998;158:33-39.
50. Leipzig RM. Avoiding adverse drug effects in elderly patients. Cleve Clin J Med 1998;65:470-477.
51. Monane M, Nagle B, Kelly MA. Pharmacotherapy: Strategies to control drug costs in managed care. Geriatrics 1998;53:51-52, 54, 63.
52. Furner SE, Brody JA, Jankowski LM. Epidemiology of aging. In: Cassel CK, et al, eds. Geriatric Medicine. 3rd ed. New York, NY: Springer Publishing Co Inc;1997:37-43.
53. Avorn J, Gurwitz JH. Drug use in the nursing home. Ann Intern Med 1995;123:195-204.
54. Slone PD. Alternatives to physical and pharmacological restraints in long-term care. Am Fam Physician 1992;15:763-769.
55. Llorente MD, Olsen EJ, Leyva O, et al. Use of antipsychotic drugs in nursing homes: Current compliance with OBRA regulations. J Am Geriatr Soc 1998;46:198-201.
56. Shorr RI, Fought RL, Ray WA. Changes in antipsychotic drug use in nursing homes during implementation of the OBRA-87 regulations. JAMA 1994;27:358-362.
57. Health Care Financing Administration. 1999 Federal Long-term Care Survey Process and Interpretive Guidelines:F329. National Information Network: Sunbury, OH;1999.
58. Lipton HL, Bero LA, Bird JA, McPhee SJ. The impact of clinical pharmacist's consultations on physician's geriatric drug prescribing: A randomized controlled trial. Med Care 1992;30:646-655.
59. Schmidt IK, Claesson CB, Westerhom B, Nilsson LG. Physician and staff assessments of drug interventions and outcomes in Swedish nursing homes. Ann Pharmacother 1998;32:27-32.
60. Leape LL, Cullen DJ, Dempsey Clapp M, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA 1999;282:267-270.
61. Schanock CT, Maswaba TR, McBride JM, Clark T. Automated order-entry mechanism to influence prescribing. Top Hosp Pharm Manage 1994;14:21-29.
62. Monane M, Matthias DM, Nagle BA, Kelly MA. Improving prescribing patterns for the elderly through an online drug utilization review intervention: A system of linking the physician, pharmacist and computer. JAMA 1998;280:1249-1252.
63. Raschke RA, Gollihare B, Wunderlich TA, et al. A computer alert system to prevent injury from adverse drug events: Development and evaluation in a community teaching hospital. JAMA 1998;280:1317-1320.
64. Hammerlun ER, Ostrom JR, Kethley AJ. The effect of drug counseling and other educational strategies on drug utilization of the elderly. Med Care 1985;23:165-179.
65. Hopper SV, Miller JP, Birge C, Swift J. A randomized study of the impact of home health aides on diabetic control and utilization patterns. Am J Public Health 1984;74:600-602.
66. Eraker SA, Kitscht JP, Becker MH. Understanding and improving patient compliance. Ann Intern Med 1984;100:258-268.
67. O'Connell MB, Johnson JF. Evaluation of medication knowledge in elderly persons. Ann Pharmacother 1992;26:919-921.
68. Green LW, Mullen KD, Stanbrook GL. Programs to reduce drug errors in the elderly: Direct and indirect evidence of patient education. J Geriatr Drug Ther 1986;1:3-17.
69. Peveler R, George C, Kimmonth A, Campbell M, Thompson C. Effect of antidepressant drug counseling and information leaflets on adherence to drug treatment in primary care: Randomized controlled trial. BMJ 1999;319:612-615.
70. Creary L, Brooks T. Ethnogeriatrics: Unique health issues of culturally diverse elderly. In: Yoshikawa TT, Cobbs EL, Brummel-Smith K, eds. Practical Ambulatory Geriatrics. 2nd ed. St. Louis, MO: Mosby;1998:80-92.
71. Knight W. Too much or too little? The role of pharmaceuticals in the health care system. J Manag Care Pharm 1999;5:296-302.
72. Neumann PJ, Hermann RC, Kuntz KM, et al. Cost-effectiveness of donepezil in the treatment of mild or moderate Alzheimer's disease. Neurology 1999;52:1138-1145.
73. Goldberg SL. Where have nursing homes been? Where are they going? Generations 1995;19:78-81.